Kingworld Medicines Group Limited provided consolidated earnings guidance for the year ended 31 December 2023. For the year, the Group is expected to record an increase in the profit of the Group attributable to owners of the Company by approximately 65% to 75% for the Year as compared to the profit of the Group attributable to owners of the Company of RMB 22.7 million for the year ended 31 December 2022 (the ?Previous Year?).